Post Authorization Safety Study of the Intramuscular Inactivated, Split Virion Pandemic A/H1N1 Influenza Vaccines in Children Aged Over 2 Months and in Adult Populations.
Phase of Trial: Phase IV
Latest Information Update: 10 Jan 2014
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Sanofi
- 21 Jul 2011 Actual end date (Jul 2011) added as reported by ClinicalTrials.gov.
- 21 Jul 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 25 Dec 2009 New trial record